The National Pharmacovigilance Conference is an annual event that brings together experts to discuss the latest developments in drug safety and pharmacovigilance. This year’s event, held in Oviedo, Spain, offered valuable insights on topics such as artificial intelligence in healthcare, innovative reporting methods, and the growing importance of communication in pharmacovigilance.
PVpharm was proud to participate, exchanging ideas with industry leaders and exploring new ways to enhance pharmacovigilance practices.
National Pharmacovigilance Conference Session
Key Highlights from the Conference
- Artificial Intelligence for Safety and Efficiency
Artificial intelligence (AI) was a key topic this year. Experts discussed how AI tools like diagnostics, predictive analytics, and text analysis can improve drug safety and efficiency. While AI has great potential to streamline processes, the speakers emphasized the challenges, including the need for secure and responsible handling of healthcare data.
- Improving Adverse Reaction Reporting Systems
Improving adverse reaction reporting was another focus of the conference. Speakers highlighted digital tools and strategies to involve patients directly in reporting. These innovations aim to make the process faster and more accurate, which ultimately contributes to better public health protection.
- Data-Driven Approaches in Pharmacoepidemiology
The power of data in pharmacovigilance took center stage. Experts reviewed Spanish data sources and showcased how real-world evidence can improve drug safety monitoring. They stressed that accessible, high-quality data is essential for identifying trends and managing risks effectively.
- Effective Communication in Pharmacovigilance
Clear and timely communication is vital in pharmacovigilance. The conference emphasized how platforms like social media can help raise awareness about drug safety. Influencers and healthcare journalists shared strategies for delivering trustworthy, simple messages to patients and healthcare professionals, empowering them to make informed decisions.
PVpharm Team’s Participation
PVpharm’s Contribution to the Event
PVpharm presented two poster presentations, one of them received the first prize of the category
PVpharm presented two poster communications, one related to the Aula de Farmacovigilancia, and another with other members of AEFI that was awarded the first prize of the category.
Learning and Sharing Expertise
PVpharm was honored to join this year’s conference. Our team engaged with industry experts, exchanged ideas, and gained insights that will help us enhance our services.
Commitment to Safer Healthcare
By staying aligned with industry trends and embracing innovative solutions, we are more committed than ever to advancing pharmacovigilance. Through data-driven approaches and effective communication, we aim to contribute to safer healthcare practices for all.
Check this: PVpharm: Solving the Riddle of Pharmacovigilance Compliance.
